These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34224684)

  • 1. Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.
    Povsic TJ; Henry TD; Ohman EM; Pepine CJ; Crystal RG; Rosengart TK; Reinhardt RR; Dittrich HC; Traverse JH; Answini GA; Mokadam NA
    Am Heart J; 2021 Nov; 241():38-49. PubMed ID: 34224684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial.
    Nakamura K; Henry TD; Traverse JH; Latter DA; Mokadam NA; Answini GA; Williams AR; Sun BC; Burke CR; Bakaeen FG; DiCarli MF; Chaitman BR; Peterson MW; Byrnes DG; Ohman EM; Pepine CJ; Crystal RG; Rosengart TK; Kowalewski E; Koch GG; Dittrich HC; Povsic TJ;
    Circ Cardiovasc Interv; 2024 May; 17(5):e014054. PubMed ID: 38696284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EXACT Trial: Results of the Phase 1 Dose-Escalation Study.
    Povsic TJ; Henry TD; Traverse JH; Anderson RD; Answini GA; Sun BC; Arnaoutakis GJ; Boudoulas KD; Williams AR; Dittrich HC; Tarka EA; Latter DA; Ohman EM; Peterson MW; Byrnes D; Pepine CJ; DiCarli MF; Crystal RG; Rosengart TK; Mokadam NA
    Circ Cardiovasc Interv; 2023 Aug; 16(8):e012997. PubMed ID: 37503661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment.
    Stewart DJ; Hilton JD; Arnold JM; Gregoire J; Rivard A; Archer SL; Charbonneau F; Cohen E; Curtis M; Buller CE; Mendelsohn FO; Dib N; Page P; Ducas J; Plante S; Sullivan J; Macko J; Rasmussen C; Kessler PD; Rasmussen HS
    Gene Ther; 2006 Nov; 13(21):1503-11. PubMed ID: 16791287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF gene therapy for angiogenesis in refractory angina: phase I/II clinical trial.
    Kalil RA; Salles FB; Giusti II; Rodrigues CG; Han SW; Sant'Anna RT; Ludwig E; Grossman G; Prates PR; Sant'anna JR; Teixeira Filho GF; Nardi NB; Nesralla IA
    Rev Bras Cir Cardiovasc; 2010; 25(3):311-21. PubMed ID: 21103738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and biodistribution of XC001 (encoberminogene rezmadenovec) gene therapy in rats: a potential therapy for cardiovascular diseases.
    Stewart DJ; Gianchetti A; Byrnes D; Dittrich HC; Thorne B; Manza LL; Reinhardt RR
    Gene Ther; 2024 Jan; 31(1-2):45-55. PubMed ID: 37592080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramyocardial, autologous CD34+ cell therapy for refractory angina.
    Losordo DW; Henry TD; Davidson C; Sup Lee J; Costa MA; Bass T; Mendelsohn F; Fortuin FD; Pepine CJ; Traverse JH; Amrani D; Ewenstein BM; Riedel N; Story K; Barker K; Povsic TJ; Harrington RA; Schatz RA;
    Circ Res; 2011 Aug; 109(4):428-36. PubMed ID: 21737787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.
    Khan AR; Farid TA; Pathan A; Tripathi A; Ghafghazi S; Wysoczynski M; Bolli R
    Circ Res; 2016 Mar; 118(6):984-93. PubMed ID: 26838794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up.
    Hartikainen J; Hassinen I; Hedman A; Kivelä A; Saraste A; Knuuti J; Husso M; Mussalo H; Hedman M; Rissanen TT; Toivanen P; Heikura T; Witztum JL; Tsimikas S; Ylä-Herttuala S
    Eur Heart J; 2017 Sep; 38(33):2547-2555. PubMed ID: 28903476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial.
    Jolicœur EM; Banai S; Henry TD; Schwartz M; Doucet S; White CJ; Edelman E; Verheye S
    Trials; 2013 Feb; 14():46. PubMed ID: 23413981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
    Povsic TJ; Henry TD; Traverse JH; Fortuin FD; Schaer GL; Kereiakes DJ; Schatz RA; Zeiher AM; White CJ; Stewart DJ; Jolicoeur EM; Bass T; Henderson DA; Dignacco P; Gu Z; Al-Khalidi HR; Junge C; Nada A; Hunt AS; Losordo DW;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1576-85. PubMed ID: 27491607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.
    Kastrup J; Jørgensen E; Rück A; Tägil K; Glogar D; Ruzyllo W; Bøtker HE; Dudek D; Drvota V; Hesse B; Thuesen L; Blomberg P; Gyöngyösi M; Sylvén C;
    J Am Coll Cardiol; 2005 Apr; 45(7):982-8. PubMed ID: 15808751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of VEGF-2 in no-option patients.
    Reilly JP; Grise MA; Fortuin FD; Vale PR; Schaer GL; Lopez J; VAN Camp JR; Henry T; Richenbacher WE; Losordo DW; Schatz RA; Isner JM
    J Interv Cardiol; 2005 Feb; 18(1):27-31. PubMed ID: 15788051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study.
    Banai S; Ben Muvhar S; Parikh KH; Medina A; Sievert H; Seth A; Tsehori J; Paz Y; Sheinfeld A; Keren G
    J Am Coll Cardiol; 2007 May; 49(17):1783-9. PubMed ID: 17466229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.
    Losordo DW; Schatz RA; White CJ; Udelson JE; Veereshwarayya V; Durgin M; Poh KK; Weinstein R; Kearney M; Chaudhry M; Burg A; Eaton L; Heyd L; Thorne T; Shturman L; Hoffmeister P; Story K; Zak V; Dowling D; Traverse JH; Olson RE; Flanagan J; Sodano D; Murayama T; Kawamoto A; Kusano KF; Wollins J; Welt F; Shah P; Soukas P; Asahara T; Henry TD
    Circulation; 2007 Jun; 115(25):3165-72. PubMed ID: 17562958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris.
    Grines CL; Watkins MW; Helmer G; Penny W; Brinker J; Marmur JD; West A; Rade JJ; Marrott P; Hammond HK; Engler RL
    Circulation; 2002 Mar; 105(11):1291-7. PubMed ID: 11901038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.
    Rosengart TK; Lee LY; Patel SR; Sanborn TA; Parikh M; Bergman GW; Hachamovitch R; Szulc M; Kligfield PD; Okin PM; Hahn RT; Devereux RB; Post MR; Hackett NR; Foster T; Grasso TM; Lesser ML; Isom OW; Crystal RG
    Circulation; 1999 Aug; 100(5):468-74. PubMed ID: 10430759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary autologous CD34+ stem cell therapy for intractable angina.
    Wang S; Cui J; Peng W; Lu M
    Cardiology; 2010; 117(2):140-7. PubMed ID: 20975266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia.
    Rodrigo SF; van Ramshorst J; Mann I; Leong DP; Cannegieter SC; Al Younis I; Dibbets-Schneider P; de Roos A; Fibbe WE; Zwaginga JJ; Bax JJ; Schalij MJ; Beeres SL; Atsma DE
    Int J Cardiol; 2014 Aug; 175(3):539-44. PubMed ID: 25023791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.